Literature DB >> 30739581

Novel Paracrine Functions of Smooth Muscle Cells in Supporting Endothelial Regeneration Following Arterial Injury.

Jun Ren1, Ting Zhou1, Vijaya Satish Sekhar Pilli1, Noel Phan1, Qiwei Wang1, Kartik Gupta1, Zhenjie Liu1,2, Nader Sheibani3, Bo Liu1.   

Abstract

RATIONALE: Regeneration of denuded or injured endothelium is an important component of vascular injury response. Cell-cell communication between endothelial cells and smooth muscle cells (SMCs) plays a critical role not only in vascular homeostasis but also in disease. We have previously demonstrated that PKCδ (protein kinase C-delta) regulates multiple components of vascular injury response including apoptosis of SMCs and production of chemokines, thus is an attractive candidate for a role in SMC-endothelial cells communication.
OBJECTIVE: To test whether PKCδ-mediated paracrine functions of SMCs influence reendothelialization in rodent models of arterial injury. METHODS AND
RESULTS: Femoral artery wire injury was performed in SMC-conditional Prkcd knockout mice, and carotid angioplasty was conducted in rats receiving transient Prkcd knockdown or overexpression. SMC-specific knockout of Prkcd impaired reendothelialization, reflected by a smaller Evans blue-excluding area in the knockout compared with the wild-type controls. A similar impediment to reendothelialization was observed in rats with SMC-specific knockdown of Prkcd. In contrast, SMC-specific gene transfer of Prkcd accelerated reendothelialization. In vitro, medium conditioned by AdPKCδ-infected SMCs increased endothelial wound closure without affecting their proliferation. A polymerase chain reaction-based array analysis identified Cxcl1 and Cxcl7 among others as PKCδ-mediated chemokines produced by SMCs. Mechanistically, we postulated that PKCδ regulates Cxcl7 expression through STAT3 (signal transducer and activator of transcription 3) as knockdown of STAT3 abolished Cxcl7 expression. The role of CXCL7 in SMC-endothelial cells communication was demonstrated by blocking CXCL7 or its receptor CXCR2, both significantly inhibited endothelial wound closure. Furthermore, insertion of a Cxcl7 cDNA in the lentiviral vector that carries a Prkcd shRNA overcame the adverse effects of Prkcd knockdown on reendothelialization.
CONCLUSIONS: SMCs promote reendothelialization in a PKCδ-dependent paracrine mechanism, likely through CXCL7-mediated recruitment of endothelial cells from uninjured endothelium.

Entities:  

Keywords:  STAT3 transcription factor; chemokines, CXC; endothelial cells; muscle, smooth; protein kinase C-delta; regeneration

Mesh:

Substances:

Year:  2019        PMID: 30739581      PMCID: PMC6459708          DOI: 10.1161/CIRCRESAHA.118.314567

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  61 in total

1.  Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury.

Authors:  C P Regan; P J Adam; C S Madsen; G K Owens
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Smooth muscle cell phenotypic switching in atherosclerosis.

Authors:  Delphine Gomez; Gary K Owens
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

3.  Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells.

Authors:  Sebastiano Miscia; Marco Marchisio; Alfredo Grilli; Valentina Di Valerio; Lucia Centurione; Giuseppe Sabatino; Francesco Garaci; Giorgio Zauli; Ezio Bonvini; Angela Di Baldassarre
Journal:  Cell Growth Differ       Date:  2002-01

4.  Tumour necrosis factor-alpha and interleukin-6 release during primary percutaneous coronary intervention for acute myocardial infarction is related to coronary collateral flow.

Authors:  Roby D Rakhit; Christian Seiler; Kerstin Wustmann; Stephan Zbinden; Stephan Windecker; Bernhard Meier; Franz R Eberli
Journal:  Coron Artery Dis       Date:  2005-05       Impact factor: 1.439

5.  Cytokine response after percutaneous coronary intervention in stable angina: effect of selective glycoprotein IIb/IIIa receptor antagonism.

Authors:  Andreas W Bonz; Björn Lengenfelder; Martina Jacobs; Jörg Strotmann; Stefanie Held; Georg Ertl; Wolfram Voelker
Journal:  Am Heart J       Date:  2003-04       Impact factor: 4.749

6.  In vivo and in vitro studies on endothelial regeneration.

Authors:  P Clopath; K Müller; W Stäubli; R R Bürk
Journal:  Haemostasis       Date:  1979

7.  MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells.

Authors:  Y Zhang; G Liu; Z Dong
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

8.  Role and regulation of STAT3 phosphorylation at Ser727 in melanocytes and melanoma cells.

Authors:  Masanobu Sakaguchi; Masahiro Oka; Tetsushi Iwasaki; Yasuo Fukami; Chikako Nishigori
Journal:  J Invest Dermatol       Date:  2012-03-15       Impact factor: 8.551

9.  Tumor necrosis factor-alpha plays an important role in restenosis development.

Authors:  Pascalle S Monraats; Nuno M M Pires; Abbey Schepers; Willem R P Agema; Lianne S M Boesten; Margreet R de Vries; Aeilko H Zwinderman; Moniek P M de Maat; Pieter A F M Doevendans; Robbert J de Winter; René A Tio; Johannes Waltenberger; Leen M 't Hart; Rune R Frants; Paul H A Quax; Bart J M van Vlijmen; Louis M Havekes; Arnoud van der Laarse; Ernst E van der Wall; J Wouter Jukema
Journal:  FASEB J       Date:  2005-12       Impact factor: 5.191

10.  ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1.

Authors:  Thorsten Kessler; Lu Zhang; Ziyi Liu; Xiaoke Yin; Yaqian Huang; Yingbao Wang; Yi Fu; Manuel Mayr; Qing Ge; Qingbo Xu; Yi Zhu; Xian Wang; Kjestine Schmidt; Cor de Wit; Jeanette Erdmann; Heribert Schunkert; Zouhair Aherrahrou; Wei Kong
Journal:  Circulation       Date:  2015-02-20       Impact factor: 29.690

View more
  7 in total

Review 1.  Vascular Endothelial Cells and Innate Immunity.

Authors:  Ying Shao; Jason Saredy; William Y Yang; Yu Sun; Yifan Lu; Fatma Saaoud; Charles Drummer; Candice Johnson; Keman Xu; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-27       Impact factor: 8.311

Review 2.  Bioprinted microvasculature: progressing from structure to function.

Authors:  Alexis J Seymour; Ashley D Westerfield; Vincent C Cornelius; Mark A Skylar-Scott; Sarah C Heilshorn
Journal:  Biofabrication       Date:  2022-02-23       Impact factor: 9.954

3.  Mechanical and Structural Adaptation of the Pulmonary Root after Ross Operation in a Murine Model.

Authors:  Claudia Cattapan; Mila Della Barbera; Arben Dedja; Piero Pavan; Giovanni Di Salvo; Jolanda Sabatino; Martina Avesani; Massimo Padalino; Alvise Guariento; Cristina Basso; Vladimiro Vida
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

4.  Loss of Transforming Growth Factor Beta Signaling in Aortic Smooth Muscle Cells Causes Endothelial Dysfunction and Aortic Hypercontractility.

Authors:  Jay Zhu; Stoyan Angelov; Ilkay Alp Yildirim; Hao Wei; Jie Hong Hu; Mark W Majesky; Frank V Brozovich; Francis Kim; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-15       Impact factor: 10.514

5.  Low doses of zeolitic imidazolate framework-8 nanoparticles alter the actin organization and contractility of vascular smooth muscle cells.

Authors:  Divya Kota; Lin Kang; Alex Rickel; Jinyuan Liu; Steve Smith; Zhongkui Hong; Congzhou Wang
Journal:  J Hazard Mater       Date:  2021-02-24       Impact factor: 14.224

Review 6.  Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer.

Authors:  Qianmiao Wu; Huaijun Tu; Jian Li
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

7.  Human iPSC-Derived Vascular Smooth Muscle Cells in a Fibronectin Functionalized Collagen Hydrogel Augment Endothelial Cell Morphogenesis.

Authors:  Kaiti Duan; Biraja C Dash; Daniel C Sasson; Sara Islam; Jackson Parker; Henry C Hsia
Journal:  Bioengineering (Basel)       Date:  2021-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.